Clinical Trial Update: Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab with chemotherapy and SBRT for limited metastatic head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Jun-Lin Yi, MD | Conditions: Head and Neck Squamous Cell Carcinoma, Metastases | Phase 2 | Status: UNKNOWN